Arbutus Biopharma
ABUS
ABUS
63 hedge funds and large institutions have $442M invested in Arbutus Biopharma in 2015 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 31 increasing their positions, 10 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
57% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 23
Holders
63
Holding in Top 10
1
Calls
$4.05M
Puts
$2.95M
Top Buyers
| 1 | +$18.2M | |
| 2 | +$11.9M | |
| 3 | +$11.7M | |
| 4 |
AWG
Alpha Wave Global
New York
|
+$4.71M |
| 5 |
RIM
RS Investment Management
San Francisco,
California
|
+$4.7M |
Top Sellers
| 1 | -$47.4M | |
| 2 | -$12.2M | |
| 3 | -$5M | |
| 4 |
TCP
Tourbillon Capital Partners
New York
|
-$4.8M |
| 5 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
-$4.08M |